Health Capital Helsinki
  • Home
  • Why Helsinki Metropolitan
  • About
  • News
  • Events
  • Opportunities
  • Careers
  • Contact
  • Search
  • Menu Menu
Feb 27, 2023

Promising results by CleverHealth Network:

Collaborative digital health innovations for clinical needs

Finland’s CleverHealth Network is an ecosystem led by HUS Helsinki University Hospital, bringing together clinicians and companies to co-create better treatment solutions for patients and successful export products for companies. The first digital health solutions are now progressing towards commercialisation.

CleverHealth Network‘s multidisciplinary collaboration between Helsinki University Hospital, companies, and research institutions generates new digital solutions for identified clinical needs by harnessing health data, AI, and machine learning, resulting in impactful treatments that improve the quality of life for patients and raise the efficiency of health care processes.

Results: New digital solutions for acute leukemia, gestational diabetes and dialysis

Three research and development projects have now reached the commercialisation stage:

A clinical tumour board application has been developed to automate cancer diagnostics and ease the election to suitable treatment for patients suffering from acute leukemia. The app, developed through collaboration of HUS, TietoEvry, Productivity Leap and Hematoscope, will be used in weekly oncological meetings as well as in research.

An automated end-to-end service solution to provide a safe home-based dialysis for dialysis patients, thus easing their daily life, has been created by HUS, Aalto University, University of Helsinki and Gillie. Medical staff has access to a user interface providing real-time data.

Mobile application to treat gestational diabetes improves the glycaemic control for expecting mothers by bringing real-time data on glycaemic levels and the lifestyle choices of mothers-to-be. The app will soon be piloted on a wider scale in maternity and child health clinics. The project partners are HUS, Aalto University, University of Helsinki Fujitsu and Elisa.

AI algorithm identifying life-threatening cerebrovascular disorder

More promising results by CleverHealth Network comes from AI Head Analysis project, a collaboration of HUS, CGI and Planmeca developing an AI-based tool set for analysing head computed tomography (CT) scans to identify and localise a life-threatening cerebrovascular disorder, subarachnoid hemorrhage.

New research results were recently published in the prestigious Neurology journal, proving that the accuracy of the created algorithm is excellent and has the potential to significantly improve the timely diagnosis of patients. In addition, the AI model has been made accessible to the entire research community.

Read more

More news

Health Capital Helsinki

Close-up of unrecognizable woman using nasal sprayMarko Verch / Flickr

Researchers developed a potential key for future pandemics

Mar 31, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2023/03/Woman-nasal-spray_Flickr-1500x1000-1.jpg 1001 1500 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-03-31 12:47:332023-03-31 12:49:24Researchers developed a potential key for future pandemics
MVision AI software on a laptopMVision AI

Helsinki-based MVision AI raises EUR5.4M to speed up cancer treatment

Mar 27, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2023/03/MVision-image-w1200.jpg 675 1200 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-03-27 15:16:222023-03-29 14:41:55Helsinki-based MVision AI raises EUR5.4M to speed up cancer treatment
Two researchers in white coats walkingKeksi Agency via City of Helsinki

TILT Biotherapeutics, rising superstar of oncolytic immunotherapy

Mar 21, 2023
https://healthcapitalhelsinki.fi/wp-content/uploads/2020/04/Keksi-Agency-via-City-of-Helsinki_communications.jpg 1653 2480 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2023-03-21 08:00:272023-03-29 15:04:22TILT Biotherapeutics, rising superstar of oncolytic immunotherapy
All news

Health Capital Helsinki

Helsinki Partners
Kasarmikatu 36
00130 HELSINKI
FINLAND

Privacy notice

Sign up to our newsletter

Subscribe

Follow us

  • twitter
  • linkedin
Health Capital Helsinki
Scroll to top

We use cookies to give you the best experience on our website.

Find out more and set your preferences settings.

Powered by  GDPR Cookie Compliance
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential website cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are necessary to deliver the website as intended, refusing them will have impact how our site functions. You can always block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will prompt you to accept or refuse cookies every time you revisit our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Third party cookies

This website uses Twitter's and LinkedIn's cookies to help us improve our content and reach.

Please enable essential website cookies first so that we can save your preferences!

Privacy notice

You can read about how we use your data on our Privacy notice page.

Privacy notice